Author:
Focaccia R,de Mello RF,Montes PS,Conti FM
Publisher
Peertechz Publications Private Limited
Reference69 articles.
1. Replication of subgenomic HCV virus RNAs in a hepatoma cell line;Lohmann;Science,1999
2. Production of infectious HCV virus in tissue culture from a cloned viral genome;Wakita;Nat Med,2005
3. Treatment of HCV infection by targeting microRNA;Janssen;N Engl J Med,2013
4. The phase 3 C-EDGE treatment-naive (TN) study of a 12-week oral regimen of grazoprevir (GZR, MK-5172)/elbasvir (EBR, MK-8742) in patients with chronic HCV genotype (GT) 1, 4, or 6 infection;Zeuzem;Program and abstracts of the 50th Annual Meeting of the European Association for the Study of the Liver Abstract G,2015
5. 5. Kwo P, Gane E, Peng CY (2015) Efficacy and safety of grazoprevir/elbasvir ± RBV for 12 or 16 weeks in patients with HCV G1, G4, or G6 infection who previously failed peginterferon/RBV: C-EDGE treatment-experienced. Program and abstracts of the 50th Annual Meeting of the European Association for the Study of the Liver Abstract P0886 .
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献